EVAR术后II型内漏的预测与进展分层:临床、解剖与超声参数
该研究纳入172例EVAR术后超声随访患者(40例T2EL,132例无T2EL),回顾性收集至首次合格术后超声复查的临床与影像数据,并前瞻性随访。采用多因素logistic回归预测T2EL发生,采用有序logistic回归构建进展评分。T2EL发生模型表观AUC为0.934,Bootstrap乐观校正AUC为0.915;T2EL患者中进展模型表观AUC为0.751。
要点
- T2EL发生与术前解剖、侧支血管条件及基线患者因素相关,发生模型表观AUC达0.934。
- 已形成T2EL者,瘤囊进展与超声衍生的血流动力学及体积负荷相关,进展模型表观AUC为0.751。
- 该两步框架可能有助于术后风险分层,但模型基于有限T2EL事件,临床使用尚早。
核心结论
- EVAR术后T2EL发生主要与术前解剖、侧支血管条件和基线患者因素相关。
- 已形成T2EL者的瘤囊进展似与探索性超声衍生的血流动力学和体积负荷相关。
- 上述发现可能有助于优化术后监测和再干预选择。
研究设计与样本
- 该研究为双向性队列研究,纳入EVAR术后接受超声监测的患者。
- 以研究中心的首次合格术后超声复查为索引时间点,回顾性收集围术期临床和影像数据,此后前瞻性随访。
- 共纳入172例患者,其中40例有T2EL,132例无T2EL。
- 采用多因素logistic回归进行T2EL发生预测,采用有序logistic回归开发进展评分。
主要发现
- 高血压、较大的附壁血栓厚度、不吸烟状态、更多通畅的腰动脉、较低的下肠系膜动脉通畅评分和单侧髂内动脉栓塞被保留在T2EL发生全模型中。
- T2EL发生模型表观AUC为0.934,Bootstrap敏感性分析显示乐观校正AUC为0.915。
- T2EL患者中瘤囊增大更常见。
- T2EL患者中,高风险组有更多通畅腰动脉、更多合并髂动脉瘤、更低的下肠系膜动脉通畅评分、更厚的附壁血栓以及更高的收缩压、收缩期血流、内漏体积和内漏与瘤囊体积比。
- T2EL进展模型表观AUC为0.751。
关键数值与推荐
- T2EL中瘤囊进展定义为最大前后径瘤囊直径较基线增加至少5 mm。
- T2EL发生模型表观AUC=0.934,乐观校正AUC=0.915。
- T2EL进展模型表观AUC=0.751。
临床怎么用
- T2EL不应被视为均匀或固有良性的发现。
- 该两步框架可能作为术后风险分层的探索性策略,超越单纯内漏检测。
- 可能有助于识别需要强化监测的患者。
局限性
- 模型开发基于有限的T2EL事件。
- 超声衍生测量需要更广泛的外部验证,尽管已进行机构诊断性能和观察者间可靠性评估。
- 临床使用尚不成熟。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify factors associated with type II endoleak (T2EL) after endovascular aneurysm repair (EVAR) and to stratify sac progression risk in patients with established T2EL using clinical, anatomic, and ultrasound-derived parameters. METHODS: This ambispective cohort study included patients undergoing postoperative ultrasound surveillance after EVAR. Using the first eligible postoperative ultrasound revisit at the study center as the index time point, perioperative clinical and imaging data up to that revisit were collected retrospectively, and patients were prospectively followed thereafter. Multivariable logistic regression was used for occurrence prediction. In T2EL, sac progression was defined as an increase of at least 5 mm in maximal anteroposterior sac diameter from baseline, and ordinal logistic regression was used to develop a progression score. RESULTS: A total of 172 patients were included, 40 with T2EL and 132 without. Hypertension, greater mural thrombus thickness, nonsmoking status, more patent lumbar arteries, a lower inferior mesenteric artery patency score, and unilateral internal iliac artery embolization were retained in the full T2EL occurrence model. The occurrence model showed high apparent discrimination (apparent area under the curve [AUC] = 0.934), and bootstrap sensitivity analysis showed an optimism-corrected AUC of 0.915. Sac enlargement was more frequent in T2EL. Among T2EL patients, the high-risk group had more patent lumbar arteries, more concomitant iliac aneurysms, lower inferior mesenteric artery patency scores, thicker mural thrombus, and higher systolic pressure, systolic flow, endoleak volume, and endoleak-to-sac volume ratio. The progression model showed moderate discrimination (apparent AUC = 0.751). CONCLUSION: T2EL occurrence after EVAR was associated mainly with preoperative anatomy, collateral vessel conditions, and baseline patient factors, whereas sac progression in established T2EL appeared to be associated with exploratory ultrasound-derived hemodynamic and volumetric burden. These findings may help refine postoperative surveillance and selection for reintervention.Clinical ImpactType II endoleak after EVAR should not be managed as a uniform or inherently benign finding. In our cohort, T2EL occurrence was associated mainly with preoperative anatomy, collateral-vessel status, and baseline patient factors, whereas sac progression among established T2EL cases appeared to be associated with exploratory ultrasound-derived hemodynamic and volumetric burden. This 2-step framework may provide an exploratory strategy for postoperative risk stratification beyond simple endoleak detection and may help identify patients requiring intensified surveillance. However, because model development was based on limited T2EL events and ultrasound-derived measurements require broader external validation despite institutional diagnostic-performance and interobserver reliability assessments, clinical use remains premature.
引用
- Li R, Wu X, Mu X, et al. Prediction and Progression Stratification of Type II Endoleak After EVAR Using Clinical, Anatomical, and Ultrasound Parameters. J Endovasc Ther. 2026. PMID: 42610688. doi:10.1177/15266028261474361
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。